Biotech · Private company
Xynomic Pharmaceuticals, Inc.
Track this companyFree. Adds Xynomic Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AbexinostatPhase 3 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PazopanibPhase 3 · Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AbexinostatPhase 2 · Follicular LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaPHASE1 · RECRUITING · started Jun 26, 2023ClinicalTrials.gov NCT05698524 · fetched Nov 12, 2026
- Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell LymphomaPHASE1 · COMPLETED · started May 29, 2019ClinicalTrials.gov NCT03939182 · fetched Nov 12, 2026
- Study of Abexinostat in Patients With Relapsed or Refractory Follicular LymphomaPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 27, 2018ClinicalTrials.gov NCT03600441 · fetched Nov 12, 2026
- Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesPHASE1 · COMPLETED · started Aug 20, 2018ClinicalTrials.gov NCT03590054 · fetched Nov 12, 2026
- A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)PHASE3 · RECRUITING · started Jul 17, 2018ClinicalTrials.gov NCT03592472 · fetched Nov 12, 2026
- Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid TumorsPHASE1 · COMPLETED · started Jun 25, 2012ClinicalTrials.gov NCT01543763 · fetched Nov 12, 2026